Drugs / DS-2741a
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04211415 | Jan → Mar 2020 | atopic eczema | Daiichi Sankyo | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DS-2741a | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04211415 ↗ |
| Route | Subcutaneous | “Single, subcutaneous injection (upper arm, upper part of the thigh, or abdominal wall in principle) administered weekly for 4 weeks” NCT04211415 ↗ |